Source: The Financial Express

V-ensure Pharma Technologies: Contract drug maker V-Ensure gets Rs 130 cr from Investcorp, Tanas Capital

For Investcorp this is the third healthcare investment in the country and its first in the pharmaceutical sector, the firm said in a statement.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
CEO Avatar

CEO

Sathyanarayana Vemula

CEO Approval Rating

90/100

Read more